Viking Therapeutics, Inc. (LON: 0VQA)
London
· Delayed Price · Currency is GBP · Price in USD
32.73
-0.69 (-2.07%)
At close: Jan 31, 2025
Viking Therapeutics Employees
Viking Therapeutics had 27 employees as of December 31, 2023. The number of employees increased by 6 or 28.57% compared to the previous year.
Employees
27
Change (1Y)
6
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-2.39M GBP
Market Cap
2.94B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Viking Therapeutics News
- 3 days ago - Viking Therapeutics Inc (VKTX) to Announce Q4 and Year-End 2024 Financial Results - GuruFocus
- 3 days ago - Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2024 on February 5, 2025 - PRNewsWire
- 4 days ago - Lightning Round: I like WM very much, says Jim Cramer - CNBC
- 5 days ago - (VKTX) - Analyzing Viking Therapeutics's Short Interest - Benzinga
- 9 days ago - Viking Therapeutics: Cooling Market Sentiments Surrounding GLP1s - Much Uncertainties Ahead - Seeking Alpha
- 10 days ago - Viking Therapeutics: Investors Meeting Reality Of The Obesity Market - Seeking Alpha
- 10 days ago - Why this Weight-Loss Drug Stock Could Gain 200% - Barrons
- 11 days ago - Top 3 Health Care Stocks That Could Blast Off This Quarter - Benzinga